Literature DB >> 27610935

Gender differences in snus versus nicotine gum for cigarette avoidance among a sample of US smokers.

Alicia Allen1, Rachel Isaksson Vogel2, Ellen Meier3, Amanda Anderson3, Joni Jensen3, Herbert H Severson4, Dorothy Hatsukami5.   

Abstract

INTRODUCTION: Women are more susceptible to the harmful effects of cigarette smoking. Thus, identifying effective harm reduction approaches for women is necessary. The goal of this project was to examine gender differences in response to snus versus nicotine gum for cigarette avoidance, as a means of harm reduction.
METHODS: Participants were randomly assigned to use snus or nicotine gum as a method to avoid cigarette smoking. Participants attended clinic visits to receive study product, as well as provide biological samples to assess smoking avoidance and biomarkers and report on use of study product and cigarettes. A secondary analysis comparing men and women by randomization to study product was conducted.
RESULTS: Participants (n=391; 47% women) were randomized into the snus group (n=196; 45% women) and the gum group (n=195; 49% women). Men used more snus whereas women used more gum (p=0.02). During treatment, men in the snus group had higher total nicotine equivalent values whereas women did not vary by group (p=0.03). Overall, fewer men in the snus group completely avoided cigarettes compared to men in the gum group (e.g., continuous abstinence at Week 12: odds ratio=0.43, 95% confidence interval=0.20-0.93). Among women, there were no differences by randomization in cigarette avoidance.
CONCLUSIONS: Despite a number of gender differences in response to snus versus nicotine gum, these data suggest that snus may not be an optimal harm reduction approach for either gender.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cigarette smoking; Gender differences; Harm reduction; Nicotine replacement; Snus

Mesh:

Substances:

Year:  2016        PMID: 27610935      PMCID: PMC5215723          DOI: 10.1016/j.drugalcdep.2016.08.624

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  21 in total

Review 1.  Summary of the epidemiological evidence relating snus to health.

Authors:  Peter N Lee
Journal:  Regul Toxicol Pharmacol       Date:  2010-12-14       Impact factor: 3.271

2.  The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts.

Authors:  David T Levy; Elizabeth A Mumford; K Michael Cummings; Elizabeth A Gilpin; Gary Giovino; Andrew Hyland; David Sweanor; Kenneth E Warner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-12       Impact factor: 4.254

3.  Role of snus in initiation and cessation of tobacco smoking in Sweden.

Authors:  L M Ramström; J Foulds
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

4.  Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers.

Authors:  Jian-Min Yuan; Aleksandar D Knezevich; Renwei Wang; Yu-Tang Gao; Stephen S Hecht; Irina Stepanov
Journal:  Carcinogenesis       Date:  2011-07-06       Impact factor: 4.944

Review 5.  The effect on health of switching from cigarettes to snus - a review.

Authors:  Peter N Lee
Journal:  Regul Toxicol Pharmacol       Date:  2013-02-26       Impact factor: 3.271

6.  Young adults' favorable perceptions of snus, dissolvable tobacco products, and electronic cigarettes: findings from a focus group study.

Authors:  Kelvin Choi; Lindsey Fabian; Neli Mottey; Amanda Corbett; Jean Forster
Journal:  Am J Public Health       Date:  2012-07-19       Impact factor: 9.308

Review 7.  Sex differences in nicotine effects and self-administration: review of human and animal evidence.

Authors:  K A Perkins; E Donny; A R Caggiula
Journal:  Nicotine Tob Res       Date:  1999-12       Impact factor: 4.244

8.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

9.  Women and Smoking: The Effect of Gender on the Epidemiology, Health Effects, and Cessation of Smoking.

Authors:  Alicia M Allen; Cheryl Oncken; Dorothy Hatsukami
Journal:  Curr Addict Rep       Date:  2014-01-10

10.  Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.

Authors:  Dorothy K Hatsukami; Herbert Severson; Amanda Anderson; Rachael Isaksson Vogel; Joni Jensen; Berry Broadbent; Sharon E Murphy; Steven Carmella; Stephen S Hecht
Journal:  Tob Control       Date:  2015-05-19       Impact factor: 7.552

View more
  2 in total

1.  Intention to purchase alternative tobacco products as a function of smoking status and responses to advertising, packaging, and sensory experiences.

Authors:  Akshika Sharma; Kristie M June; Kaila J Norton; Brian Fix; Maansi Bansal-Travers; Vaughan W Rees; Richard J O'Connor
Journal:  Addict Behav       Date:  2022-02-22       Impact factor: 4.591

Review 2.  Effectiveness and Safety Profile of Alternative Tobacco and Nicotine Products for Smoking Reduction and Cessation: A Systematic Review.

Authors:  Neily Zakiyah; Febby V Purwadi; Widya N Insani; Rizky Abdulah; Irma M Puspitasari; Melisa I Barliana; Ronny Lesmana; Amaliya Amaliya; Auliya A Suwantika
Journal:  J Multidiscip Healthc       Date:  2021-07-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.